Financhill
Back

Intra-Cellular Therapies Stock Price Chart

Sell
28

ITCI
Intra-Cellular Therapies

Last Price:
65.54
Seasonality Move:
-6.93%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.

Intra-Cellular Therapies Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 66.24 Sell
20-day SMA: 67.87 Sell
50-day SMA: 68.8 Sell
200-day SMA: 62.96 Buy
8-day EMA: 66.36 Sell
20-day EMA: 67.5 Sell
50-day EMA: 68.38 Sell
200-day EMA: 64.73 Buy

Intra-Cellular Therapies Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 42.8 Sell
Chaikin Money Flow: -109969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.75 - 72.21) Sell
Bollinger Bands (100): (65.8 - 71.96) Sell

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Intra-Cellular Therapies Stock

Is Intra-Cellular Therapies Stock a Buy?

ITCI Technical Analysis vs Fundamental Analysis

Sell
28
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy or a Sell?

Intra-Cellular Therapies Stock Info

Market Cap:
6.92B
Price in USD:
65.54
Share Volume:
628.39K

Intra-Cellular Therapies 52-Week Range

52-Week High:
84.89
52-Week Low:
45.50
Sell
28
Intra-Cellular Therapies (ITCI) is a Sell

Intra-Cellular Therapies Share Price Forecast

Is Intra-Cellular Therapies Stock a Buy?

Fundamental Analysis of Intra-Cellular Therapies

Is Intra-Cellular Therapies a good investment?

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Technical Analysis of Intra-Cellular Therapies

Should I short Intra-Cellular Therapies stock?

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.